Key Highlights

● ACN closed at $208.39 on 9 October 2026, and the $219.15 consensus target implies upside of about 5.2%.

● The consensus draws on 27 analysts, with targets from $130 to $282, while a second data set shows a $223.65 average.

● Market data shows 11 Buy, 14 Hold and two Sell ratings, a Hold consensus.

● Truist raised its target to $220 from $150 and RBC to $240 from $175 on 2 October, part of a broad wave of increases.

Accenture plc (NYSE:ACN), the global professional services and IT consulting firm, is a member of the S&P 500. The shares closed at $208.39 on Friday 9 October 2026, after an unusually large wave of analyst target increases in early October.

What Is the Latest Analyst Price Target?

Market data shows a consensus price target of $219.15 from 27 analysts in the last 12 months. The range is very wide, from $130.00 to $282.00. Compared with the $208.39 close, the consensus implies upside of about 5.2%.

The second data set, which also counts 27 analysts, reports an average of $223.65 and a median of $223, with targets from $163 to $275, implying about 7% upside. Both sets of figures were updated in the days after the early-October revisions. Sixteen named broker targets published since late August average about $222, in line with both data sets.

What Are Wall Street Analysts Saying?

Opinion is cautious. Market data lists 11 Buy, 14 Hold and two Sell ratings, a Hold consensus, and the second data set shows nine Strong Buy, two Buy and 16 Hold ratings with no Sells.

Early October brought a burst of increases. On 2 October Truist raised its target from $150 to $220 (Hold), RBC from $175 to $240 (Outperform), Argus from $220 to $260 (Buy) and Morgan Stanley from $175 to $195 (Equal Weight). Goldman Sachs raised from $230 to $260 on 1 October, Susquehanna from $153 to $210 and TD Cowen from $173 to $193. Mizuho lifted its target from $226 to $241 on 6 October. BMO Capital Markets set a $235 target, Baird $245 and Evercore $250.

Not everyone is positive. Wells Fargo reiterated a Reduce rating on 2 October, and an independent ratings service maintained a Sell (D+) rating on 6 October.

What Could Help the Stock Reach the Price Target?

The latest results gave analysts something to work with. Market data reports fourth-quarter earnings per share of $3.29 against a $3.18 consensus estimate, and revenue of $18.68 billion against $18.03 billion expected. Fiscal 2027 revenue guidance is $76.4 billion to $78.7 billion.

The broad upward revision of targets, often from low bases, shows that many brokers have become more constructive. If the company delivers within its guidance, those brokers may feel vindicated, although the shares would need to rise only about 5% to reach the market data consensus.

What Could Prevent the Stock Reaching the Target?

Sentiment towards the sector is evidently fragile. Many of the increases were from very low targets, such as Truist's $150, Susquehanna's $153 and Deutsche Bank's earlier move from $136 to $175, which indicates how far expectations had fallen. Several brokers still rate the shares Hold, and the wide range from $130 to $282 reflects genuine disagreement.

Analysts may also be reacting to a share-price move rather than leading it, and targets can be cut again if conditions worsen.

What Should Investors Watch Next?

Further target and rating changes, delivery against the fiscal 2027 guidance range and sentiment towards the consulting sector will all be worth monitoring.

Accenture's Target Rebound Starts From a Very Low Base

Accenture closed at $208.39 on 9 October 2026, with the $219.15 consensus target about 5.2% above it and the second data set's $223.65 average about 7% above. Fourth-quarter earnings per share of $3.29 and revenue of $18.68 billion beat estimates, and fiscal 2027 revenue guidance of $76.4 billion to $78.7 billion gave brokers something to work with. Yet many early-October increases started from very low targets, such as Truist's $150 and Susquehanna's $153, and Wells Fargo kept a Reduce rating, so the $130 to $282 range still reflects genuine disagreement.